Taken together, these results suggest TRMT6/61A regulates m1A levels on tRF-3s in tumors, and that the elevation of TRMT6/61A in BLCA is associated with the expected induction of tRF-3 targets in tumors. Here, TBPL2 is linked to bladder transitional cell carcinoma.